Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06555588 · ClinicalTrials.gov registry record · NA
Engage Psychosocial Intervention for Cancer Symptoms
A NA study of Advanced Breast Cancer and Advanced Colorectal Carcinoma, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 1
- Study location
NCT06555588 is a NA study of Advanced Breast Cancer and Advanced Colorectal Carcinoma that is actively recruiting participants, run by Duke University. The registered enrollment target is 190 participants, below the 458-participant average among 28 other Advanced Breast Cancer trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06555588, a NA study of Advanced Breast Cancer and Advanced Colorectal Carcinoma, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test the efficacy a new psychosocial symptom management intervention called ENGAGE for patients with Stage IV breast, prostate, lung, or colorectal cancer. Participants will be randomized to ENGAGE or a Supportive Care intervention. Patient-reported outcomes will be assessed at baseline, 2 months, and 4 months.
Conditions Studied
Interventions
- BEHAVIORAL ENGAGE
- BEHAVIORAL Supportive Care
Study Locations (1)
North Carolina
- Duke Cancer Network - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2028-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06555588
The ClinicalTrials.gov registry entry for NCT06555588 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 458-participant average among 28 other Advanced Breast Cancer trials with a reported enrollment target (59% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Advanced Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which ENGAGE is the first listed.
NCT06555588 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06555588 about?
NCT06555588 is a clinical study titled "Engage Psychosocial Intervention for Cancer Symptoms". The goal of this clinical trial is to test the efficacy a new psychosocial symptom management intervention called ENGAGE for patients with Stage IV breast, prostate, lung, or colorectal cancer. Participants will be randomized to ENGAGE or a Supportive Care intervention. Patient-reported outcomes wil...
What is the current status of trial NCT06555588?
This trial is currently recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2025-06-11. Estimated completion is 2028-11.
What conditions does trial NCT06555588 study?
This clinical trial studies the following conditions: Advanced Breast Cancer, Advanced Colorectal Carcinoma, Advanced Prostate Cancer, Advanced Lung Cancer, Advanced Colorectal Adenocarcinoma.
What interventions are being tested in trial NCT06555588?
The interventions under investigation include: ENGAGE (BEHAVIORAL), Supportive Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT06555588?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06555588 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The COMPASSION Study
RECRUITING · NA
-
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
RECRUITING · NA
-
Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer
COMPLETED · NA
-
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
RECRUITING · Phase 2
-
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Advanced Breast Cancer
All registered trials for this condition
Advanced Colorectal Carcinoma
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.